SCHEMBL4285375

SCHEMBL4285375

CC(=O)C(Oc1ccccc1)(N1CCCCC1)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.38
CYP2B6 P20813 1/20 0.38
EPHX2 P34913 1/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CHRM3 P20309 4/20 0.35
NPSR1 Q6W5P4 3/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285371 0.74 CYP2B6 (0.41) HPGDCYP2B6EPHX2GAASMN1; SMN2
SCHEMBL4285382 0.71 GAA (0.50) HPGDEPHX2GAASMN1; SMN2NPC1
Acetic Acid SCHEMBL29103732 0.67 EPHX2 (0.50) EPHX2SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL23903305 0.67 ALDH1A1 (0.50) HPGDEPHX2GAASMN1; SMN2NPC1
SCHEMBL30608899 0.65 CYP2B6 (0.43) CYP2B6MAPTCHRM3NPSR1MEN1
SCHEMBL28515156 0.64 EPHX2 (0.47) EPHX2SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL9680992 0.64 ALDH1A1 (0.51) CYP2B6GAASMN1; SMN2NPC1RAB9A
SCHEMBL11513547 0.63 L3MBTL1 (0.42) NPC1RAB9AMAPTLMNAMEN1
SCHEMBL13072375 0.63 PPARA (0.50) MAPTKDM4EMEN1KMT2ATSHR
SCHEMBL26059882 0.63 PDK1 (0.43) MAPTKDM4EMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069300-A2 MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PREXA PHARMACEUTICALS, INC. (US) 2009-06-17 EP disclosed
WO-2008024371-A2 MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PREXA PHARMACEUTICALS, INC. (US) 2008-02-28 WO disclosed